Sarah Tevis
Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 47 | 2026 | 2365 | 11.690 |
Why?
| | Patient Reported Outcome Measures | 14 | 2026 | 496 | 5.460 |
Why?
| | Mastectomy | 19 | 2026 | 174 | 5.370 |
Why?
| | Postoperative Complications | 24 | 2026 | 2950 | 3.040 |
Why?
| | Mastectomy, Segmental | 10 | 2025 | 107 | 3.020 |
Why?
| | Mammography | 6 | 2025 | 166 | 2.780 |
Why?
| | Comprehension | 5 | 2025 | 182 | 2.550 |
Why?
| | Health Literacy | 4 | 2025 | 184 | 2.230 |
Why?
| | Quality of Life | 15 | 2026 | 3183 | 2.220 |
Why?
| | Mammaplasty | 5 | 2025 | 139 | 2.080 |
Why?
| | Patient Education as Topic | 4 | 2026 | 771 | 1.990 |
Why?
| | Patient Satisfaction | 8 | 2026 | 707 | 1.950 |
Why?
| | Analgesics, Opioid | 7 | 2025 | 1142 | 1.890 |
Why?
| | Surgical Procedures, Operative | 9 | 2024 | 272 | 1.870 |
Why?
| | Internship and Residency | 7 | 2022 | 1262 | 1.770 |
Why?
| | Drug Prescriptions | 4 | 2025 | 283 | 1.710 |
Why?
| | Postoperative Care | 3 | 2026 | 286 | 1.700 |
Why?
| | Sexual Health | 2 | 2026 | 66 | 1.680 |
Why?
| | General Surgery | 5 | 2021 | 206 | 1.550 |
Why?
| | Patient Readmission | 13 | 2025 | 765 | 1.520 |
Why?
| | Quality Improvement | 12 | 2026 | 1287 | 1.510 |
Why?
| | Female | 76 | 2026 | 78304 | 1.420 |
Why?
| | Humans | 103 | 2026 | 144667 | 1.370 |
Why?
| | Breast Implants | 3 | 2025 | 31 | 1.340 |
Why?
| | Prophylactic Mastectomy | 2 | 2021 | 10 | 1.280 |
Why?
| | Surveys and Questionnaires | 19 | 2026 | 6041 | 1.210 |
Why?
| | Adult | 42 | 2026 | 40489 | 1.210 |
Why?
| | Practice Patterns, Physicians' | 6 | 2025 | 1360 | 1.200 |
Why?
| | Middle Aged | 41 | 2026 | 35971 | 1.180 |
Why?
| | Aged | 37 | 2026 | 25955 | 1.150 |
Why?
| | Colectomy | 4 | 2016 | 106 | 1.090 |
Why?
| | Communication | 3 | 2023 | 972 | 1.020 |
Why?
| | Patient Safety | 4 | 2021 | 353 | 1.020 |
Why?
| | Ovarian Neoplasms | 2 | 2023 | 589 | 1.000 |
Why?
| | Internet | 4 | 2026 | 698 | 0.990 |
Why?
| | Electronic Health Records | 3 | 2024 | 1176 | 0.970 |
Why?
| | Education, Medical, Graduate | 3 | 2021 | 562 | 0.930 |
Why?
| | Ovariectomy | 3 | 2023 | 163 | 0.930 |
Why?
| | Breast | 3 | 2023 | 157 | 0.920 |
Why?
| | Oncologists | 1 | 2026 | 46 | 0.900 |
Why?
| | Patients | 2 | 2023 | 182 | 0.880 |
Why?
| | Physician-Patient Relations | 3 | 2026 | 589 | 0.880 |
Why?
| | Symptom Assessment | 1 | 2026 | 136 | 0.870 |
Why?
| | Nomograms | 2 | 2015 | 59 | 0.870 |
Why?
| | Meaningful Use | 1 | 2024 | 13 | 0.860 |
Why?
| | Surgeons | 4 | 2023 | 341 | 0.850 |
Why?
| | Breast Implantation | 2 | 2025 | 21 | 0.820 |
Why?
| | Patient-Centered Care | 4 | 2025 | 545 | 0.780 |
Why?
| | Physicians | 2 | 2023 | 949 | 0.770 |
Why?
| | Lymphoma, Large-Cell, Anaplastic | 2 | 2022 | 22 | 0.770 |
Why?
| | Pancreatectomy | 1 | 2026 | 286 | 0.770 |
Why?
| | Preoperative Care | 2 | 2024 | 379 | 0.760 |
Why?
| | Carcinoma, Ductal, Breast | 2 | 2025 | 88 | 0.750 |
Why?
| | Medical Errors | 2 | 2021 | 119 | 0.750 |
Why?
| | Hysterectomy | 2 | 2023 | 137 | 0.730 |
Why?
| | Social Media | 1 | 2025 | 167 | 0.720 |
Why?
| | Literacy | 1 | 2022 | 13 | 0.720 |
Why?
| | Quality of Health Care | 3 | 2018 | 692 | 0.710 |
Why?
| | Colonic Neoplasms | 1 | 2024 | 256 | 0.700 |
Why?
| | Prognosis | 11 | 2026 | 4312 | 0.700 |
Why?
| | Retrospective Studies | 25 | 2026 | 17149 | 0.690 |
Why?
| | Delayed Diagnosis | 2 | 2020 | 98 | 0.690 |
Why?
| | Lymph Node Excision | 4 | 2025 | 173 | 0.690 |
Why?
| | Paternalism | 1 | 2021 | 4 | 0.680 |
Why?
| | Interviews as Topic | 2 | 2025 | 905 | 0.680 |
Why?
| | Referral and Consultation | 3 | 2024 | 852 | 0.660 |
Why?
| | Access to Information | 1 | 2021 | 47 | 0.660 |
Why?
| | Chemoprevention | 1 | 2021 | 91 | 0.660 |
Why?
| | Early Detection of Cancer | 1 | 2026 | 472 | 0.660 |
Why?
| | Oxycodone | 1 | 2021 | 53 | 0.650 |
Why?
| | Neoplasm Recurrence, Local | 4 | 2025 | 1145 | 0.650 |
Why?
| | Surgical Wound Infection | 2 | 2022 | 330 | 0.640 |
Why?
| | Artificial Intelligence | 1 | 2025 | 381 | 0.630 |
Why?
| | Specialties, Surgical | 1 | 2021 | 82 | 0.630 |
Why?
| | Sentinel Lymph Node Biopsy | 6 | 2025 | 117 | 0.620 |
Why?
| | Risk Management | 1 | 2020 | 83 | 0.620 |
Why?
| | Cancer Survivors | 1 | 2025 | 330 | 0.620 |
Why?
| | Carcinoma, Lobular | 1 | 2020 | 55 | 0.610 |
Why?
| | Length of Stay | 11 | 2025 | 1339 | 0.610 |
Why?
| | Personnel Selection | 1 | 2021 | 93 | 0.610 |
Why?
| | Faculty | 1 | 2021 | 153 | 0.610 |
Why?
| | Follow-Up Studies | 10 | 2026 | 5414 | 0.600 |
Why?
| | Body Image | 3 | 2026 | 99 | 0.600 |
Why?
| | Surgical Oncology | 3 | 2026 | 30 | 0.600 |
Why?
| | Pancreatic Neoplasms | 2 | 2026 | 926 | 0.590 |
Why?
| | Radiology | 1 | 2021 | 174 | 0.580 |
Why?
| | Ileus | 2 | 2015 | 13 | 0.570 |
Why?
| | Decision Making | 1 | 2026 | 973 | 0.560 |
Why?
| | Education, Medical, Undergraduate | 1 | 2021 | 205 | 0.560 |
Why?
| | Sentinel Lymph Node | 1 | 2018 | 49 | 0.550 |
Why?
| | Financing, Personal | 1 | 2018 | 27 | 0.550 |
Why?
| | Prospective Studies | 9 | 2026 | 7994 | 0.540 |
Why?
| | HLA Antigens | 1 | 2019 | 235 | 0.540 |
Why?
| | Intraoperative Care | 1 | 2018 | 63 | 0.540 |
Why?
| | Attitude of Health Personnel | 1 | 2026 | 1180 | 0.530 |
Why?
| | Risk Factors | 18 | 2026 | 10796 | 0.520 |
Why?
| | Neoplasm, Residual | 1 | 2018 | 139 | 0.520 |
Why?
| | Patient Acceptance of Health Care | 1 | 2024 | 881 | 0.510 |
Why?
| | Fellowships and Scholarships | 1 | 2021 | 355 | 0.510 |
Why?
| | Feasibility Studies | 3 | 2026 | 1103 | 0.500 |
Why?
| | Research Design | 1 | 2022 | 1129 | 0.480 |
Why?
| | Students, Medical | 1 | 2021 | 374 | 0.480 |
Why?
| | Pain Management | 1 | 2020 | 410 | 0.480 |
Why?
| | Anastomotic Leak | 1 | 2016 | 45 | 0.470 |
Why?
| | Male | 29 | 2026 | 72431 | 0.460 |
Why?
| | Genetic Testing | 1 | 2018 | 480 | 0.460 |
Why?
| | Patient Discharge | 4 | 2026 | 985 | 0.450 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2015 | 7 | 0.440 |
Why?
| | Video Recording | 2 | 2026 | 217 | 0.420 |
Why?
| | Opioid-Related Disorders | 1 | 2022 | 601 | 0.410 |
Why?
| | Hospitals, Teaching | 1 | 2014 | 119 | 0.410 |
Why?
| | Health Care Surveys | 2 | 2015 | 537 | 0.400 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 779 | 0.400 |
Why?
| | Salpingo-oophorectomy | 2 | 2023 | 19 | 0.390 |
Why?
| | Burnout, Professional | 1 | 2020 | 483 | 0.390 |
Why?
| | Carcinoma | 1 | 2015 | 224 | 0.380 |
Why?
| | Neoplasms | 3 | 2024 | 2873 | 0.380 |
Why?
| | United States | 13 | 2025 | 16018 | 0.380 |
Why?
| | Qualitative Research | 3 | 2026 | 1668 | 0.370 |
Why?
| | Biomarkers, Tumor | 2 | 2020 | 1319 | 0.370 |
Why?
| | Longitudinal Studies | 3 | 2024 | 2942 | 0.370 |
Why?
| | Rectal Neoplasms | 1 | 2013 | 158 | 0.360 |
Why?
| | Stress, Psychological | 1 | 2020 | 1148 | 0.350 |
Why?
| | Time-to-Treatment | 1 | 2013 | 242 | 0.340 |
Why?
| | Gastroplasty | 1 | 2011 | 32 | 0.340 |
Why?
| | Neoadjuvant Therapy | 3 | 2025 | 464 | 0.330 |
Why?
| | Clinical Competence | 2 | 2021 | 1237 | 0.330 |
Why?
| | Thyroid Neoplasms | 1 | 2015 | 349 | 0.330 |
Why?
| | Reoperation | 4 | 2025 | 624 | 0.320 |
Why?
| | Program Evaluation | 3 | 2026 | 941 | 0.320 |
Why?
| | Educational Status | 2 | 2022 | 463 | 0.310 |
Why?
| | Wisconsin | 5 | 2016 | 99 | 0.300 |
Why?
| | Gastric Bypass | 1 | 2011 | 126 | 0.300 |
Why?
| | Aged, 80 and over | 9 | 2025 | 8284 | 0.300 |
Why?
| | Guideline Adherence | 2 | 2025 | 586 | 0.300 |
Why?
| | Income | 2 | 2022 | 201 | 0.290 |
Why?
| | Pilot Projects | 2 | 2026 | 1886 | 0.290 |
Why?
| | Databases, Factual | 5 | 2019 | 1494 | 0.280 |
Why?
| | Incidence | 5 | 2015 | 2892 | 0.270 |
Why?
| | Pandemics | 3 | 2021 | 1700 | 0.270 |
Why?
| | Comorbidity | 3 | 2019 | 1652 | 0.270 |
Why?
| | Chemotherapy, Adjuvant | 2 | 2023 | 427 | 0.260 |
Why?
| | Lymphatic Metastasis | 4 | 2025 | 334 | 0.260 |
Why?
| | Obesity, Morbid | 1 | 2011 | 288 | 0.250 |
Why?
| | Risk Assessment | 3 | 2026 | 3729 | 0.240 |
Why?
| | Preoperative Period | 2 | 2024 | 149 | 0.230 |
Why?
| | Smartphone | 1 | 2026 | 100 | 0.220 |
Why?
| | Gynecologic Surgical Procedures | 1 | 2025 | 66 | 0.220 |
Why?
| | Reading | 1 | 2025 | 135 | 0.210 |
Why?
| | Inappropriate Prescribing | 1 | 2025 | 65 | 0.210 |
Why?
| | Patient Portals | 1 | 2024 | 49 | 0.200 |
Why?
| | Rosa | 1 | 2023 | 1 | 0.200 |
Why?
| | Pancreas | 1 | 2026 | 341 | 0.200 |
Why?
| | Sexually Transmitted Diseases | 1 | 2025 | 163 | 0.190 |
Why?
| | Mobile Applications | 1 | 2026 | 197 | 0.190 |
Why?
| | Information Seeking Behavior | 1 | 2023 | 39 | 0.190 |
Why?
| | Operating Rooms | 2 | 2023 | 143 | 0.190 |
Why?
| | Patient Preference | 1 | 2025 | 226 | 0.190 |
Why?
| | Hospital Mortality | 3 | 2016 | 1033 | 0.190 |
Why?
| | Transgender Persons | 1 | 2026 | 207 | 0.180 |
Why?
| | Patient Navigation | 1 | 2024 | 111 | 0.180 |
Why?
| | Academic Medical Centers | 1 | 2025 | 545 | 0.180 |
Why?
| | Delivery of Health Care | 2 | 2022 | 944 | 0.180 |
Why?
| | Focus Groups | 1 | 2025 | 566 | 0.180 |
Why?
| | Time Factors | 5 | 2025 | 7140 | 0.180 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 2201 | 0.180 |
Why?
| | Electronics | 1 | 2021 | 69 | 0.170 |
Why?
| | Logistic Models | 3 | 2015 | 2114 | 0.170 |
Why?
| | Bone Marrow | 2 | 2020 | 306 | 0.170 |
Why?
| | Patient Participation | 1 | 2024 | 428 | 0.160 |
Why?
| | Language | 1 | 2024 | 323 | 0.160 |
Why?
| | Habits | 1 | 2020 | 52 | 0.160 |
Why?
| | Analgesia | 1 | 2021 | 105 | 0.160 |
Why?
| | Checklist | 1 | 2021 | 111 | 0.160 |
Why?
| | Schools, Medical | 1 | 2021 | 158 | 0.160 |
Why?
| | Interdisciplinary Communication | 1 | 2021 | 200 | 0.150 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2020 | 80 | 0.150 |
Why?
| | Nipples | 1 | 2019 | 12 | 0.150 |
Why?
| | Genotyping Techniques | 1 | 2019 | 70 | 0.150 |
Why?
| | Organ Sparing Treatments | 1 | 2019 | 37 | 0.150 |
Why?
| | Health Education | 1 | 2022 | 345 | 0.150 |
Why?
| | Adaptation, Psychological | 2 | 2023 | 718 | 0.150 |
Why?
| | Axilla | 3 | 2025 | 51 | 0.150 |
Why?
| | Program Development | 1 | 2021 | 368 | 0.140 |
Why?
| | Mentors | 1 | 2021 | 214 | 0.140 |
Why?
| | Neoplasm Invasiveness | 1 | 2020 | 503 | 0.140 |
Why?
| | Hospitals, University | 2 | 2016 | 176 | 0.140 |
Why?
| | Breast Diseases | 1 | 2018 | 23 | 0.140 |
Why?
| | Surface Properties | 1 | 2019 | 397 | 0.140 |
Why?
| | Career Choice | 1 | 2020 | 233 | 0.140 |
Why?
| | Gene Frequency | 1 | 2019 | 481 | 0.140 |
Why?
| | Biopsy | 1 | 2022 | 1079 | 0.140 |
Why?
| | Postoperative Period | 2 | 2021 | 351 | 0.140 |
Why?
| | Young Adult | 5 | 2026 | 14122 | 0.140 |
Why?
| | Sexual Behavior | 1 | 2022 | 493 | 0.140 |
Why?
| | Salaries and Fringe Benefits | 1 | 2018 | 57 | 0.140 |
Why?
| | Adolescent | 5 | 2026 | 22409 | 0.130 |
Why?
| | Confidentiality | 1 | 2018 | 80 | 0.130 |
Why?
| | Photography | 1 | 2018 | 119 | 0.130 |
Why?
| | Patient Care Team | 2 | 2021 | 690 | 0.130 |
Why?
| | Age Factors | 2 | 2025 | 3329 | 0.130 |
Why?
| | Neoplasm Staging | 3 | 2025 | 1465 | 0.120 |
Why?
| | Practice Guidelines as Topic | 1 | 2025 | 1569 | 0.120 |
Why?
| | Informed Consent | 1 | 2018 | 197 | 0.120 |
Why?
| | Markov Chains | 1 | 2017 | 130 | 0.120 |
Why?
| | Anxiety | 1 | 2024 | 1122 | 0.120 |
Why?
| | Treatment Outcome | 4 | 2025 | 11735 | 0.120 |
Why?
| | RNA, Viral | 1 | 2020 | 689 | 0.120 |
Why?
| | Alleles | 1 | 2019 | 886 | 0.120 |
Why?
| | Multivariate Analysis | 3 | 2015 | 1537 | 0.120 |
Why?
| | Proctocolectomy, Restorative | 1 | 2015 | 23 | 0.110 |
Why?
| | Bayes Theorem | 1 | 2016 | 426 | 0.100 |
Why?
| | Medicare | 1 | 2020 | 899 | 0.100 |
Why?
| | Curriculum | 1 | 2021 | 1063 | 0.100 |
Why?
| | Palliative Care | 1 | 2022 | 1011 | 0.100 |
Why?
| | Rectum | 1 | 2015 | 183 | 0.100 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1961 | 0.100 |
Why?
| | Colitis, Ulcerative | 1 | 2015 | 148 | 0.100 |
Why?
| | Emergencies | 1 | 2014 | 175 | 0.100 |
Why?
| | Urinary Tract Infections | 1 | 2015 | 206 | 0.090 |
Why?
| | Digestive System Surgical Procedures | 1 | 2013 | 110 | 0.090 |
Why?
| | Regression Analysis | 1 | 2015 | 998 | 0.090 |
Why?
| | Disease-Free Survival | 1 | 2013 | 768 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1766 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2019 | 3603 | 0.090 |
Why?
| | Global Health | 1 | 2015 | 401 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 967 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2350 | 0.080 |
Why?
| | Combined Modality Therapy | 1 | 2013 | 1268 | 0.080 |
Why?
| | Treatment Failure | 1 | 2011 | 365 | 0.080 |
Why?
| | Proportional Hazards Models | 1 | 2013 | 1322 | 0.080 |
Why?
| | Models, Biological | 1 | 2017 | 1811 | 0.070 |
Why?
| | Lymph Nodes | 2 | 2023 | 501 | 0.070 |
Why?
| | Disease Progression | 1 | 2017 | 2847 | 0.070 |
Why?
| | Cohort Studies | 1 | 2019 | 5957 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3888 | 0.070 |
Why?
| | Mutation | 1 | 2019 | 4081 | 0.070 |
Why?
| | Colorectal Neoplasms | 1 | 2015 | 849 | 0.060 |
Why?
| | Laparoscopy | 1 | 2011 | 477 | 0.060 |
Why?
| | Weight Loss | 1 | 2011 | 839 | 0.060 |
Why?
| | Operative Time | 1 | 2025 | 181 | 0.050 |
Why?
| | Workflow | 1 | 2025 | 182 | 0.050 |
Why?
| | Mastectomy, Modified Radical | 1 | 2022 | 6 | 0.050 |
Why?
| | Intraoperative Period | 1 | 2021 | 69 | 0.040 |
Why?
| | Survival Rate | 1 | 2025 | 2089 | 0.040 |
Why?
| | Organizational Culture | 1 | 2021 | 160 | 0.040 |
Why?
| | Medical Oncology | 1 | 2022 | 331 | 0.040 |
Why?
| | BRCA2 Protein | 1 | 2019 | 68 | 0.040 |
Why?
| | BRCA1 Protein | 1 | 2019 | 82 | 0.040 |
Why?
| | Pain Measurement | 1 | 2021 | 554 | 0.040 |
Why?
| | Medical Records | 1 | 2018 | 191 | 0.030 |
Why?
| | Sex Factors | 1 | 2021 | 2104 | 0.030 |
Why?
| | Health Facility Size | 1 | 2014 | 13 | 0.030 |
Why?
| | ROC Curve | 1 | 2017 | 618 | 0.030 |
Why?
| | Hospitals, High-Volume | 1 | 2014 | 50 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2014 | 331 | 0.020 |
Why?
| | Social Work | 1 | 2014 | 85 | 0.020 |
Why?
| | Quality Indicators, Health Care | 1 | 2015 | 335 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 638 | 0.020 |
Why?
| | Health Care Costs | 1 | 2015 | 425 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2015 | 732 | 0.020 |
Why?
| | Odds Ratio | 1 | 2014 | 1076 | 0.020 |
Why?
| | Health Status | 1 | 2016 | 834 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5870 | 0.020 |
Why?
| | Population Surveillance | 1 | 2013 | 484 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2014 | 539 | 0.020 |
Why?
| | Prevalence | 1 | 2016 | 2839 | 0.020 |
Why?
| | Chronic Disease | 1 | 2014 | 1810 | 0.020 |
Why?
| | Obesity | 1 | 2015 | 3070 | 0.010 |
Why?
|
|
Tevis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|